Special populations

Description: 
A reference tool used to provide clinicians with stabilization resources for substance use disorder within active duty and veteran populations, including resources on pharmacological treatment and substance titration.
Source: 
VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders
field_vote: 
Resource Type: 
Description: 
This Clinical Practice Guideline is intended to provide primary care clinicians and other healthcare providers with a framework by which to evaluate, treat, and manage the individual needs and preferences of patients with substance use disorders (SUD), leading to improved clinical outcomes. (From the website.)
Source: 
Department of Veterans Affairs and Department of Defense
field_vote: 
Description: 
Description of the FDA Pregnancy Categories with example drugs or substances.
Source: 
Drugs.com
field_vote: 
Description: 
A 585 page report by the National Center on Addiction and Substance Abuse document the evidence defining and describing the disease of addiction/risky substance use. It describes the need for and effectiveness of wide screening and interventions treatment and disease management tools and therapies as well as the populations in greatest need of therapies. The barriers to treatment, training and education gaps, and consequences and costs of inadequate prevention and treatment are all described. Finally, profound gaps between those who need treatment and those who receive quality care are described.
Source: 
National Center on Addiction and Substance Abuse
field_vote: 
Resource Type: 
Description: 
Practical tools and guidance for treating chronic pain in adults who have a history of substance use disorders. Topics include chronic pain management, treatment with opioids, substance abuse assessments and referrals.
Source: 
SAMHSA
field_vote: 
Description: 
This web page provides brief recommendations for monitoring patients undergoing buprenorphine treatment using liver function tests, and the proper actions to take if a patient develops hepatitis.
Source: 
PCSS Guidance
field_vote: 
Description: 
Presently, methadone is the recommended treatment for opioid-dependent pregnant women, but is associated with neonatal abstinence syndrome (NAS). NAS is characterized by opioid withdrawal symptoms in the newborn, which often requires longer hospitalization and treatment. Buprenorphine, FDA-approved in 2002 for the treatment of opioid dependence in non-pregnant individuals, hasn't been extensively studied during pregnancy. Yet, a new study in the New England Journal of Medicine (NEJM) found that buprenorphine offers an alternative to methadone in the treatment of opioid-dependent pregnant women. The study compared buprenorphine to methadone in 131 mothers and their newborns at eight international sites.
Source: 
New England Journal of Medicine
field_vote: 

Pages

Subscribe to Special populations